AST/ALT Ratio and Peripheral Artery Disease in a Chinese Hypertensive Population: A Cross-Sectional Study

被引:33
作者
Liu, Hui [1 ]
Zha, Xiaoyuan [2 ]
Ding, Congcong [1 ]
Hu, Lihua [1 ]
Li, Minghui [1 ]
Yu, Yu [1 ]
Zhou, Wei [3 ]
Wang, Tao [3 ]
Zhu, Lingjuan [3 ]
Bao, Huihui [3 ]
Cheng, Xiaoshu [3 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China
[2] Rancheng Community Hlth Serv Ctr, Wuyuan, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 2, Ctr Prevent & Treatment Cardiovasc Dis, Nanchang, Jiangxi, Peoples R China
关键词
AST; ALT ratio; peripheral artery disease; hypertensive; ALT; ALANINE AMINOTRANSFERASE RATIO; INSULIN-RESISTANCE; RISK-FACTORS; ASPARTATE; PREVALENCE; SEVERITY;
D O I
10.1177/00033197211004410
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Previous studies reported that the aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT) was a risk factor in cardiovascular disease. Peripheral artery disease (PAD) is an important risk factor for cardiovascular death. However, only a few studies investigated the correlations between the AST/ALT ratio and PAD. We analyzed data from 10 900 patients with hypertension from the Chinese Hypertension Registry Study; 350 patients had PAD (prevalence 3.2%). After adjusting for potential confounders, the AST/ALT ratio was independently and positively associated with risk of PAD (OR: 1.31, 95% CI, 1.13-1.59), and a significant increased risk of PAD for the third AST/ALT ratio tertile (T3) compared with the first tertile (T1; OR: 1.49, 95% CI, 1.09-2.04, P (trend) = .005) was found. Moreover, when we combined T1 and T2 into one group and used it as a reference group, the risk of PAD increased with the increase in AST/ALT; the risk ratio was 1.52 (95% CI, 1.20-1.95). A higher AST/ALT ratio (>= 1.65) was associated with PAD risk in Chinese adults with hypertension. Our results suggest that the AST/ALT ratio may help identify patients at high risk of vascular end points and might be a convenient, economical, and effective tool for evaluating the risk of atherosclerosis.
引用
收藏
页码:916 / 922
页数:7
相关论文
共 29 条
  • [1] Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Gossios, Thomas D.
    Griva, Theodora
    Anagnostis, Panagiotis
    Kargiotis, Konstantinos
    Pagourelias, Efstathios D.
    Theocharidou, Eleni
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. LANCET, 2010, 376 (9756) : 1916 - 1922
  • [2] Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study
    Britton, Kathryn A.
    Mukamal, Kenneth J.
    Ix, Joachim H.
    Siscovick, David S.
    Newman, Anne B.
    de Boer, Ian H.
    Thacker, Evan L.
    Biggs, Mary L.
    Gaziano, J. Michael
    Djousse, Luc
    [J]. VASCULAR MEDICINE, 2012, 17 (02) : 85 - 93
  • [3] Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
    Chacko, Kristina R.
    Reinus, John
    [J]. CLINICS IN LIVER DISEASE, 2016, 20 (02) : 387 - +
  • [4] AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction
    Ewid, Mohammed
    Sherif, Hossam
    Allihimy, Abdulaziz S.
    Alharbi, Shaima A.
    Aldrewesh, Dawood A.
    Alkuraydis, Sarah A.
    Abazid, Rami
    [J]. BMC RESEARCH NOTES, 2020, 13 (01)
  • [5] Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
    Fowkes, F. Gerald R.
    Rudan, Diana
    Rudan, Igor
    Aboyans, Victor
    Denenberg, Julie O.
    McDermott, Mary M.
    Norman, Paul E.
    Sampson, Uchechukwe K. A.
    Williams, Linda J.
    Mensah, George A.
    Criqui, Michael H.
    [J]. LANCET, 2013, 382 (9901) : 1329 - 1340
  • [6] Peripheral artery disease: epidemiology and global perspectives
    Fowkes, F. Gerry R.
    Aboyans, Victor
    Fowkes, Freya J. I.
    McDermott, Mary M.
    Sampson, Uchechukwu K. A.
    Criqui, Michael H.
    [J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (03) : 156 - 170
  • [7] Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI [10.1016/j.jacc.2016.11.007, 10.1161/CIR.0000000000000471]
  • [8] Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease
    Giannini, E
    Risso, D
    Botta, F
    Chiarbonello, B
    Fasoli, A
    Malfatti, F
    Romagnoli, P
    Testa, E
    Ceppa, P
    Testa, R
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (02) : 218 - 224
  • [9] Peripheral arterial disease: Morbidity and mortality implications
    Golomb, Beatrice A.
    Dang, Tram T.
    Criqui, Michael H.
    [J]. CIRCULATION, 2006, 114 (07) : 688 - 699
  • [10] Drug therapy - Medical treatment of peripheral arterial disease and claudication.
    Hiatt, WR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (21) : 1608 - 1621